09 December 2021 | Statements

Landscape report launched on novel technologies for the prevention of HIV, STIs, and unintended pregnancy

Geneva – Emerging technologies that can prevent HIV, other sexually transmitted infections and unintended pregnancies through a single administration method have the potential to respond better to user preferences, simplify service delivery, alleviate stigma, and reduce health risks. Currently, over two dozen of these tools, called multipurpose prevention technologies, are in development, demonstrating the opportunity to accelerate health impact and help achieve global health targets, according to a new landscape report jointly launched today by Unitaid, the Children’s Investment Fund Foundation, and the Initiative for Multipurpose Prevention Technologies.

From 2018 to 2020, the number of new HIV infections per year showed limited decrease. Women and girls are at heightened risk of infection in many parts of the world, particularly in sub-Saharan Africa where they made up 63% of all new infections in 2020. In addition, more than 200 million women in low- and middle-income countries who want to avoid pregnancy do not have access to modern methods of contraception.

Innovations that better address user preferences are critical to respond to these challenges. Globally, the preference for interventions that respond to several needs versus single indication products prevails across populations and geographies. The preference for multipurpose products even appears to outweigh preference for a particular delivery type, such as intravaginal rings, gels, implants, and oral pills. However, preferences for specific attributes vary, highlighting the importance of advancing a robust pipeline that offers a range of choices.

The landscape report provides an overview of the current novel technologies in development and assesses their relevance and potential in low- and middle-income countries. While the pipeline is rich, the report calls out the need to involve key populations early in the design, introduction and scale-up of new products and proactively address potential market barriers. These considerations, as well as plans for adoption, manufacturing capacity, a broad supply base and an effective introduction strategy are crucial to developing solutions that are accessible, affordable, and acceptable and truly respond to people’s needs.


Media contact

For more information and media requests:

Thalia Bayle

Communications officer

Mobile: +41 79 660 56 37

Email: baylet@unitaid.who.int

View All News

Featured News

01 July 2022

Unitaid and the Government of Kenya strengthen collaborative partnership to advance global health goals 

Read More

30 June 2022

PAHO and Unitaid launch collaboration to advance the elimination of mother-to-child transmission of Chagas disease

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.